J. Lefort

发表

Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog.

B. Vargaftig, J. Lefort, B. Vargaftig, 1974, European journal of pharmacology.

Endotoxins, asthma, and allergic immune responses.

B. Vargaftig, J. R. Lapa e Silva, J. Lefort, 2000, Toxicology.

Arthropod-Derived Histamine-Binding Protein Prevents Murine Allergic Asthma

B. Ryffel, G. Paesen, B. Vargaftig, 2004, The Journal of Immunology.

Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy

N. Mottet, A. Azzouzi, J. Lefort, 2015, Cancer Prevention Research.

Diuretic 18 F-FDG PET/CT for therapy monitoring in urothelial bladder cancer

F. Joly, N. Aide, C. Lasnon, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus

B. Vargaftig, M. Nahori, E. Hood, 2001 .

Role of eosinophilic airway inflammation in models of asthma.

B. Vargaftig, J. R. Lapa e Silva, C. Ruffié, 1997, Memorias do Instituto Oswaldo Cruz.

INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN RESPIRATORY ANAPHYLAXIS, DEMONSTRATED BY PAF-ACETHER INHIBITOR BN 52021

B. Vargaftig, P. Braquet, R. Bourgain, 1985, The Lancet.

Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma.

B. Vargaftig, P. Gounon, M. Huerre, 1999, American journal of respiratory cell and molecular biology.

Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.

P. Braquet, V. Lagente, B. Vargaftig, 1987, Prostaglandins.

Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion.

B. Vargaftig, A. Lellouch‐Tubiana, J. Lefort, 1987, International archives of allergy and applied immunology.

Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

B. Vargaftig, A. Lellouch‐Tubiana, J. Lefort, 1985, British journal of experimental pathology.

The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene

B. Vargaftig, D. Rotilio, J. Lefort, 1984, British journal of pharmacology.

Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether).

B. Vargaftig, M. Chignard, B. Boris Vargaftig, 1982, European journal of pharmacology.

BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)

B. Vargaftig, M. Chignard, J. Benveniste, 1981, Annals of the New York Academy of Sciences.

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

B. Vargaftig, M. Chignard, J. Benveniste, 1980, European journal of pharmacology.

In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.

B. Vargaftig, M. Nahori, C. Ruffié, 1996, The Journal of clinical investigation.

Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.

B. Vargaftig, A. Lellouch‐Tubiana, B. Terlain, 1991, The Journal of clinical investigation.

Cutting Edge: Invariant Vα14 NKT Cells Are Required for Allergen-Induced Airway Inflammation and Hyperreactivity in an Experimental Asthma Model1

P. van Endert, P. Askenase, M. Kronenberg, 2003, The Journal of Immunology.

Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice

B. Vargaftig, C. Créminon, S. Eum, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness.

B. Vargaftig, S. Eum, M. Huerre, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition by the immunosuppressive agent FK‐506 of antigen‐induced airways eosinophilia and bronchial hyperreactivity in mice

B. Vargaftig, S. Eum, M. Pretolani, 1997, British journal of pharmacology.

Exacerbated Th2‐mediated airway inflammation and hyperresponsiveness in autoimmune diabetes‐prone NOD mice: a critical role for CD1d‐dependent NKT cells

B. Vargaftig, M. Nahori, A. Herbelin, 2004, European journal of immunology.

Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

B. Vargaftig, A. Lellouch‐Tubiana, J. Lefort, 1988, The American review of respiratory disease.

Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.

B. Vargaftig, M. Pretolani, J. Lefort, 1988, The American review of respiratory disease.

Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsiveness.

D. Leduc, B. Vargaftig, J. Lefort, 1996, The Journal of allergy and clinical immunology.

Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs.

B. Vargaftig, C. Ruffié, M. Pretolani, 1994, American journal of respiratory and critical care medicine.

Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma.

B. Vargaftig, C. Heusser, C. Dumarey, 1999, The European respiratory journal.

Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen.

B. Vargaftig, M. Singer, J. Lefort, 2002, American journal of respiratory cell and molecular biology.

Bacterial Lipopolysaccharide Signaling Through Toll-Like Receptor 4 Suppresses Asthma-Like Responses Via Nitric Oxide Synthase 2 Activity1

B. Vargaftig, F. Cunha, M. Russo, 2003, The Journal of Immunology.

Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.

B. Vargaftig, M. Chignard, C. Broquet, 1986, European journal of pharmacology.

Suppression of asthma-like responses in different mouse strains by oral tolerance.

B. Vargaftig, A. M. D. de Faria, M. Nahori, 2001, American journal of respiratory cell and molecular biology.

Inhibition by nedocromil sodium of recombinant human interleukin-5-induced lung hyperresponsiveness to platelet-activating factor in actively sensitized guinea pigs.

B. Vargaftig, M. Pretolani, J. Lefort, 1993, The Journal of allergy and clinical immunology.

Experimental Lung Hyperreactivity: Pharmacological Control and Possible Role of Cytokines

B. Vargaftig, M. Pretolani, J. Lefort, 1993 .

Effect of human recombinant interleukin‐5 on in vitro responsiveness to PAF of lung from actively sensitized guinea‐pigs

D. Leduc, B. Vargaftig, B. Vargaftig, 1992, British journal of pharmacology.

The effect of cetirizine on antigen‐dependent leucopenia in the guinea‐pig

B. Vargaftig, A. Coyle, J. Lefort, 1991, British journal of pharmacology.

Histamine and leukotriene‐independent guinea‐pig anaphylactic shock unaccounted for by Paf‐acether

B. Vargaftig, J. Lefort, A. Detsouli, 1985, British journal of pharmacology.

Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.

B. Vargaftig, M. Pretolani, E. Malanchère, 1987, European journal of pharmacology.

Comparative pharmacology of arachidonic acid in various animal species: Platelet-mediated and platelet-independent reactions

B. Vargaftig, M. Chignard, J. Lefort, 2005, Agents and Actions.

ROLE OF PLATELETS IN ASPIRIN‐SENSITIVE BRONCHOCONSTRICTION IN THE GUINEA‐PIG; INTERACTIONS WITH SALICYLIC ACID

B. Vargaftig, B. Vargaftig, J. Lefort, 1978, British journal of pharmacology.

Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.

P. Braquet, V. Lagente, B. Vargaftig, 1986, European journal of pharmacology.

Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.

P. Braquet, V. Lagente, B. Vargaftig, 1986, Pharmacological research communications.

Pharmacological modulation of the respiratory and haematological changes accompanying active anaphylaxis in the guinea-pig.

B. Vargaftig, V. Lagente, C. Page, 1986, European journal of pharmacology.

Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.

B. Vargaftig, M. Chignard, J. Lefort, 1981, European journal of pharmacology.

Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction.

B. Vargaftig, M. Chignard, J. Lefort, 1981, Bulletin europeen de physiopathologie respiratoire.

Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella.

B. Vargaftig, M. Chignard, J. Prado-Franceschi, 1980, European journal of pharmacology.

L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis.

B. Vargaftig, M. Chignard, F. Dray, 1979, European journal of pharmacology.

Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea pig.

B. Vargaftig, F. Fouque, J. Lefort, 1979, European journal of pharmacology.

Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism.

B. Vargaftig, J. Lefort, 1977, European journal of pharmacology.

Persistence of bronchopulmonary hyper‐reactivity and eosinophilic lung inflammation after anti‐IL‐5 or ‐IL‐13 treatment in allergic BALB/c and IL‐4Rα knockout mice

B. Vargaftig, M. Nahori, C. Ruffié, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Pharmacological profile of 48740 R.P., a PAF-acether antagonist.

B. Vargaftig, I. Maridonneau-Parini, J. Randon, 1988, European journal of pharmacology.

Blockade by methylation inhibitors of the anaphylactic response of guinea‐pig lung strips

B. Vargaftig, J. Randon, J. Lefort, 1987, British journal of pharmacology.

Rapid Publication In Vivo Neutralization of Eosinophil-derived Major Basic Protein Inhibits Antigen-induced Bronchial Hyperreactivity in Sensitized Guinea Pigs

B. Vargaftig, M. Nahori, C. Ruffié, 2013 .

Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation.

B. Vargaftig, C. Bertrand, C. Heusser, 1997, International archives of allergy and immunology.

Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns.

B. Vargaftig, M. Nahori, B. Gicquel, 2001, Vaccine.

Pharmacological properties of PAF-acether in the guinea-pig: Platelet-dependent and independent reactions

B. Vargaftig, M. Chignard, J. Lefort, 1982, Agents and Actions.

Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.

B. Vargaftig, M. Barton, J. Lefort, 1982, European journal of pharmacology.

Morphological and Pharmacological Evidences for the Participation of PAF-Acether in Anaphylactic Shock in the Guinea-Pig

B. Vargaftig, V. Lagente, A. Lellouch‐Tubiana, 1987 .

Interference of a neutrophil recruitment inhibitory factor upon the accumulation of inflammatory cells and airway hyperreactivity in sensitized guinea‐pigs after intranasal antigen challenge

B. Vargaftig, B. Vargaftig, F. Cunha, 1993, British journal of pharmacology.

Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.

B. Vargaftig, P. Braquet, S. Adnot, 1986, Prostaglandins.

10 – Mechanisms of Immediate Hypersensitivity and Hyperresponsiveness: Mediators, Antagonists and Role of Interleukins

M. Martins, M. Bureau, M. Pretolani, 1993 .

Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

P. Braquet, V. Lagente, B. Vargaftig, 1986, Pharmacological research communications.

Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.

V. Lagente, B. Vargaftig, I. Maridonneau-Parini, 1985, Biochemical and biophysical research communications.

Platelet-tissue interaction: Role of platelet-activating factor (PAF-acether)

B. Vargaftig, M. Chignard, J. Benveniste, 1980, Agents and Actions.

Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea‐pig: importance of the booster injection

B. Vargaftig, C. Dumarey, J. Lefort, 1991, British journal of pharmacology.

A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.

V. Lagente, B. Vargaftig, J. Lefort, 1986, Prostaglandins.

Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models.

B. Vargaftig, M. Nahori, G. Marchal, 2008, The Journal of allergy and clinical immunology.

Sequestration into the Murine Lungs Formation and Neutrophil α from TNF-Bronchopulmonary Hyperreactivity Dissociated Systemic Administration of Endotoxin Induces

D. Leduc, P. Renesto, B. Vargaftig, 1998 .

Guinea‐pig treatment with pertussis toxin suppresses macrophage‐dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF

D. Leduc, B. Vargaftig, B. Vargaftig, 1992, British journal of pharmacology.

Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs.

B. Vargaftig, M. Pretolani, J. Lefort, 1992, European journal of pharmacology.

Pertussis toxin induces bronchopulmonary hyperresponsiveness in guinea-pigs while antagonizing the effects of formyl-L-methionyl-L-leucyl-L-phenylalanine.

D. Leduc, B. Vargaftig, A. Lellouch‐Tubiana, 1992, European journal of pharmacology.

Interference of the Paf antagonist Ro 19–3704 with Paf and antigen‐induced bronchoconstriction in the guinea‐pig

P. Hadváry, V. Lagente, B. Vargaftig, 1988, British journal of pharmacology.

Pulmonary anti-anaphylactic activity of clenbuterol tested on actively and passively sensitized guinea-pigs.

V. Lagente, B. Vargaftig, J. Lefort, 1985, European journal of pharmacology.

Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig.

B. Vargaftig, R. Murphy, J. Lefort, 1981, European journal of pharmacology.

An alternative point of view on experimental lung hyperreactivity.

B. Vargaftig, M. Pretolani, J. Lefort, 1990, Agents and actions. Supplements.

Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig.

V. Lagente, B. Vargaftig, J. Randon, 1986, International journal of immunopharmacology.

Proceedings: Role of platelet aggregation in bronchoconstriction in guinea-pigs.

B. Vargaftig, J. Lefort, 1975, British journal of pharmacology.

Alveolar macrophages and eicosanoids but not neutrophils, mediate bronchoconstriction induced by FMLP in the guinea‐pig

M. Bureau, B. Vargaftig, B. Vargaftig, 1989, British journal of pharmacology.

Reduced responsiveness of bronchoalveolar cells from sensitised guinea-pigs to the cyclic AMP--stimulating effect of prostaglandin E2 and beta-adrenoceptor agonists.

G. Béréziat, B. Vargaftig, M. Bachelet, 1989, Pulmonary pharmacology.

The booster injection of antigen during active sensitization of guinea‐pig modifies the anti‐anaphylactic activity of the PAF antagonist WEB 2086

B. Vargaftig, C. Dumarey, J. Lefort, 1990, British journal of pharmacology.

Interference of PAF-acether antagonists with the effects of PAF itself and of anaphylactic shock in in vitro and in vivo guinea-pig bronchopulmonary

V. Lagente, B. Vargaftig, J. Randon, 1985 .

Pharmacological modulation of the effects of N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine in guinea‐pigs: involvement of the arachidonic acid cascade

V. Lagente, B. Vargaftig, A. Lellouch‐Tubiana, 1986, British journal of pharmacology.

Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig

B. Vargaftig, M. Bureau, J. Dry, 1991, Agents and Actions.

LPS-induced bronchial hyperreactivity: interference by mIL-10 differs according to site of delivery.

V. Deleuze, D. Scherman, M. Bureau, 2004, American journal of physiology. Lung cellular and molecular physiology.

Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.

C. Rougeot, V. Choumet, C. Bon, 2007, Toxicology and applied pharmacology.

Mechanisms of collagen-induced bronchoconstriction and thrombocytopenia in the guinea-pig [proceedings].

B. Vargaftig, J. Lefort, 1978, British journal of pharmacology.

Synthase 2 Activity Asthma-Like Responses Via Nitric Oxide Through Toll-Like Receptor 4 Suppresses Bacterial Lipopolysaccharide Signaling

B. Vargaftig, F. Cunha, M. Russo, 2003 .

Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig.

B. Vargaftig, J. Lefort, Bernardo Boris Vargaftig, 1979, Prostaglandins.

The Role of Biologically Active Lipids in Platelet Aggregation

B. Vargaftig, M. Chignard, J. Lefort, 1979 .

Syndrome IL-2-Induced Pulmonary Vascular Leak Neutrophils Are Both Critical for NK Cells and Polymorphonuclear and

B. Vargaftig, J. Thèze, E. Assier, 2004 .

Enhancement by prostacyclin of the contractility of the guinea-pig airways smooth muscle.

B. Vargaftig, J. Lefort, 1981, European journal of pharmacology.

α‐Galactosylceramide‐induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role of IFN‐γ

P. Askenase, A. Herbelin, G. Marchal, 2005 .

Platelet-lung in vivo interactions: an artifact of a multi-purpose model?

B. Vargaftig, M. Chignard, J. Benveniste, 1979, Haemostasis.

Frontline : a-Galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice : Role of IFN-c

P. Askenase, G. Marchal, M. Dy, 2005 .

Leukotrines C and D induce aspirin-sensitive bronchoconstriction in the guine-pig

R. Murphy, B. Vargaftig, J. Lefort, 1981, Agents and Actions.

Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine

B. Vargaftig, C. Labat, S. Eum, 1999, British journal of pharmacology.

Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome.

B. Vargaftig, J. Thèze, J. R. Lapa e Silva, 2005, Cytokine.

Role of platelets and of prostaglandin synthetase on hypotensive effects of arachidonic acid and of carrageenan

B. Vargaftig, J. Lefort, 1977 .

Haemorrhagic and inflammatory properties of collagenase fromC. histolyticum

B. Vargaftig, E. Giroux, J. Lefort, 1976, Agents and Actions.

Platelet effects of arachidonic acid in dog blood. I. Lack of involvement of cyclo-oxygenase in the in vivo situation.

B. Vargaftig, M. Chignard, J. Lefort, 1977, Prostaglandins.

Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig.

B. Vargaftig, M. Bachelet, C. Dumarey, 1990, The American review of respiratory disease.

AN UNEXPECTED EFFECT OF SEROTONIN ANTAGONISTS ON THE CANINE NASAL CIRCULATION

B. Vargaftig, E. Schönbaum, J. Lefort, 1975, Headache.

Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs.

D. Leduc, P. Renesto, B. Vargaftig, 1998, Journal of immunology.

NK Cells and Polymorphonuclear Neutrophils Are Both Critical for IL-2-Induced Pulmonary Vascular Leak Syndrome1

J. D. Di Santo, B. Vargaftig, J. Thèze, 2004, The Journal of Immunology.

Salicylic acid prevents inhibition by aspirin of arachidonic acid-induced hypotension, bronchoconstriction and thrombocytopenia [proceedings].

B. Vargaftig, J. Lefort, 1977, British journal of pharmacology.

PAF-acether and experimental anaphylaxis as a model for asthma.

B. Vargaftig, M. Bachelet, A. Lellouch‐Tubiana, 1989, International archives of allergy and applied immunology.

Germinal Center Formation and Local Immunoglobulin E (IgE) Production in the Lung after an Airway Antigenic Challenge

J. Bonnefoy, Y. Chvatchko, S. Herren, 1996, The Journal of experimental medicine.

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.

P. Askenase, A. Herbelin, G. Marchal, 2005, European journal of immunology.

Limited interference of specific Paf antagonists with hyper‐responsiveness to Paf itself of lungs from actively sensitized guinea‐pigs

B. Vargaftig, M. Pretolani, J. Lefort, 1989, British journal of pharmacology.

Platelet effects of arachidonic acid in dog blood. II. Involvement of cyclo-oxygenase in the in vitro situation.

B. Vargaftig, M. Chignard, J. Lefort, 1977, Prostaglandins.

Effect of cyclo‐oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide‐induced neutrophil infiltration in mouse lung

B. Vargaftig, M. Chignard, A. Meager, 1996, British journal of pharmacology.

Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation.

B. Vargaftig, J. Lefort, L. Motreff, 2001, American journal of respiratory cell and molecular biology.

Structure-activity relationship in PAF-acether. 2. rac-1-O-Octadecyl-2-O-acetyl-3-O-[gamma-(dimethylamino)propyl]glycerol .

C. Broquet, F. Heymans, J. Godfroid, 1985, Journal of medicinal chemistry.

Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.

B. Vargaftig, M. Pina, J. Lefort, 1993, European Journal of Pharmacology.

Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.

B. Vargaftig, C. Dumarey, M. Pretolani, 1989, The Journal of pharmacology and experimental therapeutics.

Intratracheal E. coli lipopolysaccharide induces platelet-dependent bronchial hyperreactivity.

B. Vargaftig, M. Bureau, J. Dry, 1993, Journal of applied physiology.

A genome-wide screen for asthma-associated quantitative trait loci in a mouse model of allergic asthma.

W. Cookson, B. Vargaftig, Youming Zhang, 1999, Human molecular genetics.

New vistas on the role of platelets in bronchoconstrictions.

B. Vargaftig, M. Chignard, J. Lefort, 1979, Agents and actions. Supplements.

Role of eosinophilic airway inflammation in models of asthma.

B. Vargaftig, M. Pretolani, J. Lefort, 1997, Memorias do Instituto Oswaldo Cruz.